Skip to main content
Signal8

Sweetnam Paul

SEC insider (Form 3/4/5 filer). CIK 0002156367. CHIEF SCIENTIFIC OFFICER at Retension Pharmaceuticals, Inc. (RTSN). 2 reported Form 4/5 transactions since Sep 2024; latest on Oct 13, 2026. Located in FALLS CHURCH, VA.

Companies Sweetnam Paul has filed insider reports for

  • Retension Pharmaceuticals, Inc. (RTSN): Officer, CHIEF SCIENTIFIC OFFICER
Sweetnam Paul profile photo

Sweetnam Paul

CIK: 0002156367

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Retension Pharmaceuticals, Inc. logo
RTSN

Retension Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Retension Pharmaceuticals, Inc. logo
    RTSN

    Retension Pharmaceuticals, Inc.

    Oct 13, 2026
    Conversion
    Direct
    4K shares-
  • Retension Pharmaceuticals, Inc. logo
    RTSN

    Retension Pharmaceuticals, Inc.

    Oct 13, 2026
    Conversion
    Indirect
    2.6K shares-

1-2 of 2